CF-AIR Workshop 9/26/18
Location: ECC 302
September 26, 2018: Greg Duncan, CEO of Celtaxsys - Advancing Development of an Anti-inflammatory Therapy to Reduce Pulmonary Exacerbations in Cystic Fibrosis
More information here
Location: ECC 302
September 26, 2018: Greg Duncan, CEO of Celtaxsys - Advancing Development of an Anti-inflammatory Therapy to Reduce Pulmonary Exacerbations in Cystic Fibrosis
More information here